Keywords: second, study, shows, il-11, cuts, platelet, transfusions
Second Study Shows IL-11 Cuts Platelet Transfusions
Article | 20 May 1996
Genetics Institute's has reported the results of a second placebo-controlled Phase II study which confirms that its recombinant human interleukin-11 ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Is failure to adopt business process management putting the pharma industry at risk?
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
